Optimizing methotrexate withdrawal during COVID vaccination.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 36180548.
- Also identified by DOI 10.1038/s41584-022-00856-7 and PMC identifier 9524381.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Results from two parallel trials suggest that withholding methotrexate only after the second dose of a COVID vaccine is safe and effective in patients with rheumatoid arthritis or psoriatic arthritis.
Medical subject headings
- COVID-19
- Antirheumatic Agents
- Arthritis, Rheumatoid